RE: Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore29 Sep 2022 13:50
Let's try to educate the NUT.
Here's a post taken from Ngen Yap on other BB that gives a flavour of opportunities...
It's a shame the company isn't or isn't able to shout more about the deals they have in place, and likely more in the making.
To put things into perspective, I think Ambry will easily do 100,000 NIPT tests per annum and at $100 per test for us will be $10m! That doesn't even include other tests eg DPYD and Ranger tech utilisation across the broad range of Ambry offering.
Then EKF, likely 50,000 tests and that is $5m. Plus other tests to come.
We also know we have Labcorp and ANO routinely using Ranger tech and consumables. Looking at Labcorp, they are absolutely massive. And they openly endorsed our tech for DNA sample selection.
APAC and LATM growing.....
Look forward and it's not hard to see we are SEVERELY undervalued.